Biomarkers may yield information relevant to disease outcome on three progressive levels: (i) as measurable endpoints of damage to proteins/amino acids, oxidised lipids, oxidised DNA bases, (ii) as functional markers of, for example, blood flow, platelet aggregation, or cognitive function, and (iii) as endpoints related to specific disease
How is BPC-157 proposed to work in tissue repair
Involvement of disulfide bond formation in the activation of heparanase
Uh, so if a patient maybe uh has this issue, consider whether symptoms are possible, GERD, or potentially whether its worth switching to a different med, if it really does become more bothersome